ClinicalTrials.gg
RecruitingNCT05809323Updated Jan 24, 2024

Marfan Syndrome Moderate Exercise Trial II

An interventional study of Exercise Intervention Group and Control Group in Marfan Syndrome, sponsored by Baylor College of Medicine. Recruiting at 1 site in United States. Open to participants aged 10 Years to 25 Years. Per ClinicalTrials.gov, last updated 2024-01-24.

Sponsored by Baylor College of Medicine · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Primary completion was expected by Jul 2025, 1 year 4 months ago, but the record still lists the study as recruiting.
  • Started Sep 2023; still recruiting 3 years 2 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
50
Allocation
Randomized
Ages
10 Years to 25 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 16 studies in Marfan Syndrome with a site in United States — 2 open to participants now, 3 under way, none of them phase 3. Marfan Syndrome · United States.

Planned enrollment
5th of 10
50 · median 45
Started
2023
the only one that year
No phase
7 of 16
2 open now
Registered
15th of 16
by date
Lead sponsor
2 of 16
Baylor College of Medicine

Among the 16 studies in Marfan Syndrome with a site in United States, this one is the 5th largest by planned enrollment of the 10 interventional ones that give a count, is the only one that started in 2023, is one of 7 with no phase, and was the 15th registered.

Marfan Syndrome

61 studies on the registry are indexed under Marfan Syndrome; 15 are open to participants now.

Browse Marfan Syndrome studies →

Open to participants now

2 of the 16 studies in Marfan Syndrome with a site in United States are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 12 Marfan Syndrome studies recruiting now, 7 (58%) set no upper age limit and 4 (33%) stop at 75 or younger; 9 take children under 18; 1 takes healthy volunteers.

This study: 10 Years to 25 Years · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 16 studies in Marfan Syndrome with a site in United States, or all of them as a file.
02

Study summary

Marfan syndrome (MFS) is a distinctive connective tissue disorder that affects multiple organ systems including the heart, bones, ligaments, and eyes, and is associated with significant risk of aortic dissection. Given limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities. The lack of exercise and deconditioning have detrimental effects including increasing weakness, joint pain, decreased endurance, and depressive symptoms. Given the significant paucity of data currently existing on the effects of exercise in humans with MFS, and the recent, optimistic findings in rodent models, this pilot trial was established to assess the effects of moderated dynamic exercise in adolescents and young adults with MFS.

Read the detailed description

Marfan syndrome (MFS) is a distinctive connective tissue disorder with clinical phenotypes that affect multiple organ systems including the heart, bones, ligaments, and eyes, and are associated with significant risk of aortic dissection. Given anecdotal reports of aortic dissection, limited evidence from in-vitro studies, and theoretical concerns, the majority of patients with MFS are restricted from certain physical activities, most commonly isometric exercise and contact sports. Published guidelines also suggest restriction from highly dynamic competitive sports. While clinicians may mean to restrict patients only from competitive sports, often children and families interpret this caution as applying to almost all exercise, resulting in a large number of patients with MFS being sedentary. This lack of exercise and deconditioning likely has detrimental effects in increasing weakness and joint pain and decreasing endurance. Depressive symptoms are also not uncommon in patients with these syndromes, and may be triggered or exacerbated by guidance to acutely cease participation in sports at the time of diagnosis.

To date, as far as we are aware, there are no published controlled studies on the effects of dynamic exercise on human subjects. In 2017, Mas-Stachurska et al published a study suggesting that a moderate level of dynamic exercise mitigated progressive degradation of the cardiac structures typically seen in MFS in a rodent sample. This study suggests the possibility that the fears surrounding moderate exercise in humans may be unwarranted. In addition, this study suggests that moderate exercise may actually protect the aorta and myocardium, in addition to the numerous other physical and emotional benefits that have been shown to result from consistent exercise. We have unpublished trial results in a pilot study that also suggest benefit to adolecents and young adults.

Given the significant paucity of data currently existing on effects of exercise in humans with MFS, and the recent optimistic findings in rodent models, we plan to conduct a randomized control trial of moderate dynamic exercise in adolescents and young adults with MFS.

The objective is to:

  1. Randomize 50 patients with Marfan syndrome from ages 10-25 years to current status and care (controls) versus a moderate dynamic exercise intervention, then 2) allow the control group patients to undergo the exercise intervention.The investigators will then compare outcomes between both the intervention and control groups, and between the baseline and post-intervention states. Specific outcome measures will include cardiovascular assessment: maximal oxygen uptake (max VO2), ambulatory blood pressure, segmental and central aortic stiffness, ventricular mass and volume, and endothelial function, physical assessment by the physical therapist, and quality of life/mental health assessment: health-related quality of life, depression and anxiety screening scales. The hypothesis is that the intervention of a moderate exercise program introduced by a licensed physical therapist will result in improvement in cardiovascular status, muscular health, and mental health without detrimental effects on the aortic wall.
03

Conditions studied

  • Marfan Syndrome

Browse trials for

Keywords

  • Cardiovascular
  • Moderate Exercise
  • Physical Therapy
04

Who can participate

Ages eligible
10 Years to 25 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Male and female patients diagnosed with Marfan syndrome (defined by Ghent criteria and either a pathogenic variant in FBN1 or ectopia lentis)
  • Age 10-25 years at enrollment

Exclusion criteria

Exclusion Criteria:

  1. History of aortic surgery
  2. History of spinal surgery with implanted materials that may negatively impact MRI safety or imaging quality.
  3. Diagnosis of major congenital heart disease (ASD, VSD, bicuspid aortic valve, and mitral valve prolapse will not qualify as exclusion criteria)
  4. Condition limiting the ability to perform moderate exercise.
  5. Major concurrent diagnosis that may confound the interpretation of the effect of the proposed intervention on the proposed outcome measures.
  6. Aortic dilation meeting threshold for prophylactic aortic surgical intervention (>/= 4.5 cm in diameter)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
50 participants (estimated)

Study arms

  • Experimental
    Exercise Intervention Group

    Group of up to 50 patients will randomly allocated into an experimental group at a 4:1 ratio intervention to controls. The experimental group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) in addition to exercise intervention education, demonstration, and follow up to ensure compliance and safety.

    Other: Exercise Intervention Group

  • Other
    Control Group

    Control group will be randomly allocated at a 4:1 ratio, intervention to controls.. The control group will receive all of the preliminary outcome measure testing (cardiovascular, musculoskeletal, and psychological screening) and will be instructed to continue with baseline physical activities. They will be asked to return for a reassessment of all baseline procedures (cardiovascular, musculoskeletal, and psychological screening).

    Other: Control Group

Interventions

  • OtherExercise Intervention Group

    Patients will be educated on methods of self-evaluating exertion and cardiovascular effort by assessing respiratory rate and perceived exertion. Next, patients will be given options for cardiovascular activities and complete at a moderate level of activity for a minimum of 150 minutes per week. Patients will perform a combination of exercises under the supervision of a physical therapist until a mod intensity level is reached and sustained. Patients will be taught to use the activity tracker to record their heart rate, activity, and PES. Patients will have a phone call every week to assess status, answer questions, and provide guidance on progressing intensity or duration of exercise. At the end of 12 weeks all patients will return for re-assessment.

  • OtherControl Group

    Patients in the control group will be instructed to continue with baseline physical activities over the duration of the study and be given instructions on the use of the activity tracker. At the end of 12 weeks all patients will return for re-assessment.

    Also known as: No Intervention

06

What researchers measure

Primary outcomes

  1. Maximum VO2

    Maximum VO2 in ml/kg/minute will be collected via Exercise Stress Test. Range 30-85, higher is better.

    Time frame: 4 Months

Secondary outcomes

  1. Mean systolic blood pressure

    mmHg, range 20-200, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile

    Time frame: 4 Months

  2. Mean diastolic blood pressure

    mmHg, range 20-150, both low and high are abnormal, goal is age, sex and height-based, goal 10-50 percentile

    Time frame: 4 Months

  3. Mean pulse pressure

    mmHg, systolic blood pressure minus diastolic blood pressure, range 30-70 mmHg, goal is normal range for age and sex

    Time frame: 4 Months

  4. Weight

    kg, range 50-300kg, lower is better, excluding underweight patients

    Time frame: 4 Months

  5. BMI

    kg/m2, lower is better generally, excluding pts with BMI \<5% for age

    Time frame: 4 Months

  6. Left ventricular strain by cardiac MRI

    Continuous measure derived from post-processing MRI

    Time frame: 4 Months

  7. Right ventricular strain by cardiac MRI

    Continuous measure derived from post-processing MRI

    Time frame: 4 Months

  8. Aortic root strain

    Continuous measure %, higher is less stiff, Range 0-40

    Time frame: 4 Months

  9. Aortic Root Distensibility

    ×10-3 mm Hg-1, Continuous measure, range 0.1-10

    Time frame: 4 Months

  10. Aortic Root β-Stiffness index

    No units, Range 0.1-90

    Time frame: 4 Months

  11. Maximum aortic root dimension

    Measured in cm, range 1-8cm

    Time frame: 4 Months

  12. Aortic root z-score

    No units, based on body surface area published references, range -3 to 25

    Time frame: 4 Months

  13. Aortic pulse wave velocity from MRI

    meters/second, range 0-30

    Time frame: 4 Months

  14. Pulse wave velocity derived from applanation tonometry

    meters/second, range 0-30

    Time frame: 4 Months

  15. Quality of Life Scale (QOLS) (ages 19-21 y)

    16 items, each with 7 point Likert, higher is worse

    Time frame: 4 Months

  16. Pediatric Quality of Life Scale (PedsQL) scale scores

    reported in 3 domains, each reported on Likert scale, scaled to 0-100 scale, lower is worse

    Time frame: 4 Months

  17. Patient Health Questionnaire-9 (PHQ-9)

    Nine-item questionnaire that detects depression and the severity of the depression, scaled from 0-27, higher is worse

    Time frame: 4 Months

  18. Patient Health Questionnaire-4 (PHQ-4) Subset A: Anxiety

    Four-question test for anxiety and depression, scaled from 0-12 Subset A (Anxiety): Questions 1 \& 2, which have a total PHQ 4 score range of 0 to 6. A score of 3 or greater is considered positive for screening purposes.

    Time frame: 4 Months

  19. Patient Health Questionnaire-4 (PHQ-4) Subset B: Depression

    Four-question test for anxiety and depression, scaled from 0-12, Subset B (Depression): Questions 3 \& 4, which have a total PHQ 4 score range of 0 to 6. A score of 3 or greater is considered positive for screening purposes.

    Time frame: 4 Months

  20. Generalized Anxiety Disorder 7-item (GAD-7)

    Seven-item questionnaire that detects generalized anxiety disorder and the severity of the anxiety. GAD-7 total score for the seven items ranges from 0 to 21. Using a cut-off of 8 the GAD-7 has a sensitivity of 92% and specificity of 76% for diagnosis generalized anxiety disorder.

    Time frame: Every 2 Weeks for 4 Months

  21. Pediatric Symptom Checklist Parent (PSC)

    The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English \& Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive.

    Time frame: 4 Months

  22. Pediatric Symptom Checklist Child (PSC-Y)

    The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English \& Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Attention Problems, Internalizing Problems, Externalizing Problems

    Time frame: 4 Months

  23. Pediatric Symptom Checklist Child (PSC-Y): Attention Subscale

    The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English \& Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Attention Problems Subscale: Children with subscores greater than or equal to 7 usually have significant impairments in attention.

    Time frame: 4 Months

  24. Pediatric Symptom Checklist Child (PSC-Y): Internalizing Problems Subscale

    The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English \& Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Internalizing Problems Subscale: Children with subscores greater than or equal to 5 usually have significant impairments with anxiety or depression.

    Time frame: 4 Months

  25. Pediatric Symptom Checklist Child (PSC-Y): Externalizing Problems Subscale

    The Pediatric Symptom Checklist (PSC) is a 35 item questionnaire that helps identify and assess changes in emotional and behavioral problems in children. A positive score on the PSC or Y-PSC suggests the need for further evaluation by a qualified health. PSC-35-Youth, English \& Spanish cut off score is, 30 or higher. In a Mexican-American sample, a cutoff score of 12 was shown to be most sensitive. PSC Subscales: Externalizing Problems Subscale: Children with subscores greater than or equal to 7 usually have significant problems with conduct.

    Time frame: 4 Months

  26. PROMIS Pediatric Self- Reported Psychological Stress

    PROMIS scores have a mean of 50 and standard deviation (SD) of 10 in a referent population. On the T-score metric, A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. Better health is a lower score and worse health scores higher.

    Time frame: 4 Months

  27. PROMIS Parent Proxy Reported Psychological Stress- Parent Proxy

    PROMIS scores have a mean of 50 and standard deviation (SD) of 10 in a referent population. On the T-score metric, A score of 40 is one SD lower than the mean of the reference population. A score of 60 is one SD higher than the mean of the reference population. Higher score is worse health.

    Time frame: 4 Months

07

Study locations

1 of 1 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Sep 2023 (actual). Primary completion is estimated for Jul 2025, 22 months after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Mar 30, 2023
First posted
Apr 12, 2023
StartActual
Sep 1, 2023
Primary completionEst.
Jul 1, 2025
CompletionEst.
Jul 1, 2027
Last update
Jan 24, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jan 24, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05809323
Collaborators
Southern Star Research
Responsible party
Shaine Morris (Associate Professor, Pediatrics-Cardiology, Baylor College of Medicine) — Principal investigator
First posted
Apr 12, 2023
Start date
Sep 1, 2023
Primary completion
Jul 1, 2025 (estimated)
Completion
Jul 1, 2027 (estimated)
Last update
Jan 24, 2024

Study contacts

Shaine A Morris, MD, MPH
Contact
shainem@bcm.edu
832-826-5692
Jennifer Bogardus, PT, MPT, PhD
Contact
jennifer.bogardus@utah.edu
713-794-2070
Shaine A Morris, MD, MPH
principal investigator · Baylor College of Medicine

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion